Atracurium Besylate
- Product NDC
- 25021-659
- 11-digit product format
- 250210659
- Labeler code
- 25021
- Product ID
- 25021-659_0b4ea4ae-d3aa-41b9-a567-4f57f356b1fa
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- atracurium besylate
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA091488
- Marketing category
- ANDA
- Marketing start
- 2012-05-01
- Marketing end
- 2022-09-30
- Substance
- ATRACURIUM BESYLATE
- Active strength
- 10 mg/mL
- Pharmacologic classes
- Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 25021-659-05 | 25021065905 | 10 VIAL in 1 CARTON (25021-659-05) > 5 mL in 1 VIAL | 10 vial | 2012-05-01 | 2022-09-30 | No | No | Current |